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Myxofibrosarcoma is a common sarcoma in the extremities of older people, but is rare in the head and neck
region. Here, we report the case of a 42-year-old male patient in whom myxofibrosarcoma generated from the
sinus piriformis. Histopathologically, the tumor was characterized by spindle cellular proliferation with moderate
cellular density in fibromyxoid stroma. Immunohistochemically, the tumor cells showed positive reactivity for
vimentin, Ki-67, smooth muscle actin, and CD34, but negative staining for S-100. Based on these results, the tumor
was diagnosed as a low-grade myxofibrosarcoma. Resection of the tumor was performed via a transcervical
approach. The patient’s postoperative clinical course was uneventful and no local recurrence or distant metastasis
has been found so far. The pathology, clinical characteristics, and treatment of myxofibrosarcoma are also reviewed.
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As one of the most common sarcomas, myxofibrosar-
coma (MFS) is originally described as a myxoid variant
of malignant fibrous histiocytoma (MFH), the unique
characteristic of which can be ascribed as its frequent
occurrence in the subcutaneous tissues of the extrem-
ities of older people. Myxofibrosarcoma rarely occurs in
the head and neck regions [1], and only a few corre-
sponding cases in these areas have been reported, with
3% to 10% involvement, including the larynx [2], esopha-
gus [3], sphenoid sinus [4,5], mandible [6], maxillary
sinus [7], parotid [8,9], orbit [10,11], and infratemporal
space [12]. To our knowledge, only one case has so far
been reported regarding MFS generated from the hypo-
pharynx [13].
The objective of this work was to report an additional
case of MFS arising in the sinus piriformis. The clinical,
radiological, and histopathological characteristics of this
tumor were also reviewed. Three years after operation,
the postoperative clinical course was uneventful and no
evidence of recurrence or metastasis and symptoms in
the throat were observed in this patient.* Correspondence: jingping_fan@hotmail.com
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A 42-year-old Chinese man had felt an unpleasant sen-
sation in the throat since July 2005. He visited a local
otorhinolaryngology clinic and a tumor was found in the
hypopharynx. The tumor was resected surgically under a
laryngoscope in October 2005. However, the patient still
complained of a mass coming from the deep throat
sooner after the operation. When vomiting, he could
feel the mass coming from his throat into his mouth,
and when swallowing, the mass would go downward.
A barium meal (baM) examination of the esophagus
showed that the cervical segment, about 14 cm from
the cutting tooth, was broadened to 50 mm, and the
broadened segment was 50 mm long (Figures 1a,b). An
X-ray of the chest showed that the trachea leaned to the
right (Figure 1c). A computed tomography (CT) scan
revealed an irregular-shaped mass in the esophagus,
which seemed to originate in the hypopharynx. The
mass was 90 mm long and 25 mm wide; the first 40 mm
was thin and flat, and the last 50 mm was globular
(Figures 2a,b). The patient felt that the mass had been
growing slowly over the previous 2 years. Accordingly,
he visited our hospital on November 10, 2008. On exam-
ination, we found that the surface of the mass was
smooth, like normal mucosa. The laryngeal endoscopy
and electronic gastroscopy showed that the pedicle
of the mass arose from the medial wall of the leftLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Barium meal (baM) examination of esophagus showing significant broadening in the cervical segment. (a) Front view (b) Side
view. (c, arrow) X-ray of the chest showed that the trachea leaned to the right.
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(Figures 3a,b,c). The tumor shifted downward and up-
ward when swallowing. There was no relationship be-
tween the mass and the esophageal mucosa. The pedicle
of the mass was 50 mm long, and the mass itself 40 mm
long, and this led to incomplete resection of the mass
under the laryngoscope. Based on the histological and
the pathological diagnosis of the previous surgery, we
supposed that the mass was a recurrent or persistent
MFS. We performed tumor resection and wound suture
via a transcervical approach on November 28, 2008. The
mass was well demarcated, 30 mm × 20 mm in diameter
and the cut surface was mucous yellow-gray and trans-
lucent (Figure 4).
Pathological findings showed typical features of low-
grade MFS. The tumor was characterized by spindle-cell
proliferation with moderate cellular density in the fibro-
myxoid stroma (Figure 5). Immunohistochemically, the
tumor cells were positive for vimentin, Ki-67, smooth
muscle actin (SMA), and CD34, but negative for S-100
(see Figure 6). Thus, the tumor was ultimately diagnosed
with low-grade myxofibrosarcoma (myxoid MFH). The
surgical margin was sufficient. The postoperative clinical
course was uneventful and the patient had no symptoms
in the throat after the operation.Figure 2 CT showing the mass in the esophagus. (a) The larynx was no
compressed (arrow shows the mass).Discussion
Malignant fibrous histiocytoma is the most common
malignant soft-tissue tumor in adults [14]. Histopatho-
logically, MFH can be divided into five subtypes: stori-
form-pleomorphic, myxoid, giant cell, inflammatory, and
angiomatoid [15-17]. The term MFS is proposed as a
synonym for myxoid MFH and covers a spectrum of
malignant fibroblastic lesions, which have cellular distri-
bution, pleomorphism of the nucleus, and mitotic activ-
ity that varies from a less cellular lesion with minimal
cytologic atypia to a greater cellular lesion with pro-
nounced atypical features [18,19]. Myxofibrosarcoma
usually grows slowly and painlessly in the extremities of
older people, with a slight male predominance [19].
Superficially located MFS typically consist of multiple
variably gelatinous or firmer nodules, with a myxoid cut
surface, whereas deep-seated neoplasms often form a
single mass with an infiltrative margin. However, MFS is
uncommon in the head and neck region. Only 18 cases
have been described in the head and neck so far
(Table 1), our case being the second in the hypopharynx.
Histologically, MFS may exhibit various proportions of
myxoid matrix with varied cellularity. Thus, it is sug-
gested that MFS be subdivided into four [28] or three
[29] grades according to the degree of cellularity,rmal. (b) The esophagus was dilated and the left bronchus was
Figure 3 Local finding of the hypopharynx. The tumor was located at the hypopharyngeal left sidewall. The surface was smooth and it was
the same normal color as the surrounding mucosa. (a) Arrow indicates the base of the pedicle, coming from the left piriform sinus. (b) Mass in
the pharynx when vomiting. (c) The larynx was normal.
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grade MFS shows a hypocellular to moderately cellular
architecture with a prominent myxoid matrix. Tumor
cells are fusiform, round, or stellate, with ill-defined,
slightly eosinophilic cytoplasm and atypical, enlarged,
hyperchromatic nuclei (Figure 5). Mitoses can only sel-
dom be seen [1,26]. Most of the tumors have stretched
and curved capillaries, and the tumor cells tend to be
located along the vessel periphery. Another finding
worth mentioning is the presence of prominent elon-
gated, curvilinear, thin-walled blood vessels with a peri-
vascular condensation of tumor cells or inflammatory
cells (mainly lymphocytes and plasma cells). Although
magnetic resonance imaging and CT scans evidently
make a great contribution to the visualization of malig-
nant features, such as local tissue invasion, histopatho-
logical examination is recognized as the gold standard,
for its capability to provide a definitive diagnosis [30].
Immunohistochemically, low-grade MFS is generally
positive for CD-34, vimentin [1], and sometimes for
SMA and Ki-67 [31], while negative for S-100 pro-
tein. The histopathological findings of the present case
were further consistent with a diagnosis of low-gradeFigure 4 Overall view of the tumor.myxofibrosarcoma and immunoreactivity to vimentin
and CD34, probably reflecting the tumor’s primitive
fibroblastic nature.
Complete tumor resection with adequate resection
margin remains the mainstay for treatment of MFS. The
radiotherapy is applied only for recurrent, unresectable
lesions or tumors with positive resection margins, to
suppress local recurrence and the risk of histologic pro-
gression, especially for low-grade MFS. The value of
chemotherapy in MFS is still an issue for open debate
[5]. Low-grade MFS is considered to have low malig-
nancy, and rarely shows distant metastasis, implying a
good short-term prognosis. The overall 5-year survival
rate is 60% to 70% [23]. However, the local recurrence
rate of the low-grade type is as high (50% to 60%) as that
of the high-grade type. It has continuity from low- to
high-grade subdivision, showing low-grade areas in
high-grade lesions, and a histologic progression of low-
to high-grade tumors in recurrences, hence acquiring
metastatic potential [15,29]. Therefore, these patientsFigure 5 Spindle cells proliferated in fibrous and myxoid
stroma. Arrow shows tumor cell.
Figure 6 Immunohistochemical reactivity of the tumor cells. Positive for vimentin, Ki-67, smooth muscle actin, CD34, but negative for S-100.
Vim, vimentin; SMA, smooth muscle actin.
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Complete resection of the tumor was accomplished in
our case and this patient showed no recurrence and me-
tastasis three years after the operation.
Conclusions
In summary, we report a rare case of MFS that gener-
ated from the sinus piriformis. Histopathological exam-
ination is the gold standard for offering a definitive
diagnosis, and the prognosis is accurate after complete
resection and careful surveillance. Local recurrence may
occur generally with progression of the tumor stage andTable 1 Cases of myxofibrosarcoma in the head and neck reg
Author Year Sex Age Tumor extent
Blitzer et al. [20] 1981 Male 66 Sphenoid sinus
Pomerantz et al. [21] 1982 Male 58 Maxillary sinus
Barnes and Kanbour [22] 1988 Female 67 Sphenoid sinus-c
Imai et al. [11] 2000 Female 52 Orbit
Lam et al. [23] 2002 Male 55 Left sphenoid sin
Iguchi et al. [24] 2002 Male Unknown Maxillary
Song and Miller [3] 2002 Male 40 Esophagus
Nishimura et al. [13] 2006 Male 69 Hypopharynx
Udaka et al. [1] 2006 Male 55 Neck
Enoz and Yusufhan [25] 2007 Female 36 Maxillary sinus
Gugatschka et al. [26] 2010 Male 79 Vocal folds
Xu et al. [8] 2010 Female 37 Parotid
Zhang et al. [10] 2010 Female 27 Orbit
Zouloumis et al. [6] 2010 Male 23 Mandible
Norval et al. [7] 2011 Male 69 Maxillary sinus
Srinivasan et al. [9] 2011 Female 78 Parotid
Krishnamurthy et al. [12] 2011 Female 42 Infratemporal spa
Nakahara et al. [27] 2012 Male 52 Maxillarisk of later metastasis. In this case, the hypothesis that
the tumor is recurrent may be reasonable because of the
insufficient resection in the previous operation. This
emphasizes the recurrent character of MFS and the im-
portance of sufficient resection.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the editor-in-chief of this journal.ion
Treatment Results
Radiotherapy Died after 3 months
Surgery Unknown
avernous sinus Surgery, adjuvant radiotherapy Alive after 8 months
Surgery Unknown
us Surgery Alive after 8 months
Unknown Unknown
Surgery Unknown
Surgery Alive after 16 months
Surgery Alive after 27 months
Surgery Alive after 2 years
Surgery Unknown
Surgery, radiotherapy Alive after 8 months
Surgery, radiation Alive after 6 months
Surgery, radiotherapy Alive 39 months
Radiotherapy, chemotherapy Died after 1 year
Surgery, radiotherapy Died after 24 months
ce Surgery, radiotherapy Alive after 26 months
Surgery, radiotherapy Alive after 20 months
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